NCT03504995View on ClinicalTrials.gov

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
DEVICE

Focal irreversible electroporation of the prostate cancer

Irreversible electroporation is a non-thermal tissue ablation technique in which short duration electrical fields are used to permanently permeabilize the cell membrane.

Trial Locations (1)

119991

Clinic of Urology, Sechenov University, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT03504995 - Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. | Biotech Hunter | Biotech Hunter